REX-003

N/A

Report date: 2022/11/27 23:58:42

Base Information

Drug NameREX-003
Drug Alias NameREX-003
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsIschemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRexgenero Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRexgenero Ltd
Inactive CompaniesN/A
Active IndicationsIschemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A